Clinical Trial Update: A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II clinical trial evaluating OJP-001 in adults with Adult T-cell leukemia/lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Leukemia Lymphoma

Drugs mentioned

• OJP-001

Snippet

Sponsor: Otsuka Medical Devices Co., Ltd. Japan | Conditions: Adult T-Cell Leukemia/Lymphoma (ATLL) | Phase 1, Phase 2 | Status: RECRUITING